City Therapeutics, Inc.

As Chinese biotech companies have faced a cash crunch at home, it has become necessary for them to look abroad for partnering opportunities to advance their assets through the clinic. This trend has l

Biotech leader John Maraganore has had a respected career in the industry, having built Alnylam Pharmaceuticals over 19 years into the leading RNAi therapeutics company in the world with five marketed

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. B+L Bolsters Ophthalmology With Acquis